Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma - PharmaTimes More than 71% of patients treated with Unloxcyt achieved disease control

#oncology #generics #SunPharma #Unloxcyt #cosibelimab #CSCC #squamouscellcarcinoma #mCSCC #SCC #laCSCC #FDA #CK301101 #clinicaltrial #skincancer #headandneckcancer #checkpointinhibition #checkpointinhibitor

pharmatimes.com/news/sun-pha...